Citadel Advisors - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 85 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$26,299
-62.5%
11,900
-56.9%
0.00%
Q1 2023$70,104
-82.9%
27,600
-87.4%
0.00%
Q4 2022$410,575
+183.2%
219,559
+290.1%
0.00%
Q3 2022$145,000
-37.2%
56,283
-52.9%
0.00%
Q2 2022$231,000
-30.0%
119,462
+7.6%
0.00%
Q1 2022$330,000
-60.2%
111,022
-39.9%
0.00%
Q4 2021$829,000
+181.0%
184,648
+203.5%
0.00%
Q3 2021$295,000
-41.9%
60,839
-18.3%
0.00%
Q2 2021$508,000
+37.3%
74,455
+42.1%
0.00%
Q1 2021$370,000
-40.9%
52,400
-47.7%
0.00%
Q4 2020$626,000
+350.4%
100,240
+290.0%
0.00%
Q3 2020$139,000
-50.4%
25,700
-52.2%
0.00%
Q2 2020$280,000
+207.7%
53,772
+86.8%
0.00%
Q1 2020$91,000
-78.9%
28,790
-73.1%
0.00%
Q4 2019$431,000
-3.8%
106,874
+3.1%
0.00%
Q3 2019$448,000
-1.8%
103,614
-9.3%
0.00%
Q2 2019$456,000
-20.3%
114,250
+7.2%
0.00%
Q1 2019$572,000
-26.0%
106,611
-29.2%
0.00%
Q4 2018$773,000
-15.1%
150,663
+60.5%
0.00%
Q3 2018$911,000
-73.7%
93,892
-72.4%
0.00%
-100.0%
Q2 2018$3,466,000
+50.5%
339,763
+91.8%
0.00%0.0%
Q1 2018$2,303,000
+164.7%
177,151
+264.7%
0.00%
Q4 2017$870,000
-70.1%
48,572
-58.1%
0.00%
-100.0%
Q3 2017$2,908,000
+46.5%
115,877
+40.7%
0.00%
+100.0%
Q2 2017$1,985,000
-43.0%
82,361
-54.5%
0.00%
-75.0%
Q1 2017$3,484,000
+1913.9%
181,050
+1510.8%
0.00%
Q4 2016$173,000
+101.2%
11,240
+238.7%
0.00%
Q2 2015$86,0003,3190.00%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders